Nothing Special   »   [go: up one dir, main page]

IL153282A0 - Method for preparing a pharmaceutical composition - Google Patents

Method for preparing a pharmaceutical composition

Info

Publication number
IL153282A0
IL153282A0 IL15328201A IL15328201A IL153282A0 IL 153282 A0 IL153282 A0 IL 153282A0 IL 15328201 A IL15328201 A IL 15328201A IL 15328201 A IL15328201 A IL 15328201A IL 153282 A0 IL153282 A0 IL 153282A0
Authority
IL
Israel
Prior art keywords
preparing
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IL15328201A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL153282(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL153282A0 publication Critical patent/IL153282A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15328201A 2000-06-27 2001-06-18 Method for preparing a pharmaceutical composition IL153282A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27
PCT/EP2001/006834 WO2002000201A2 (en) 2000-06-27 2001-06-18 Method for preparing a composition

Publications (1)

Publication Number Publication Date
IL153282A0 true IL153282A0 (en) 2003-07-06

Family

ID=8169074

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15328201A IL153282A0 (en) 2000-06-27 2001-06-18 Method for preparing a pharmaceutical composition
IL153282A IL153282A (en) 2000-06-27 2002-12-04 Method of preparation of a medicinal product

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153282A IL153282A (en) 2000-06-27 2002-12-04 Method of preparation of a medicinal product

Country Status (38)

Country Link
US (3) US6534087B2 (sh)
EP (1) EP1296656B1 (sh)
JP (2) JP4149803B2 (sh)
KR (1) KR100557845B1 (sh)
CN (1) CN1236764C (sh)
AR (1) AR029278A1 (sh)
AT (1) ATE334662T1 (sh)
AU (2) AU2001281846B2 (sh)
BR (1) BRPI0112014B1 (sh)
CA (1) CA2411153C (sh)
CY (1) CY1105714T1 (sh)
CZ (1) CZ301813B6 (sh)
DE (1) DE60121953T2 (sh)
DK (1) DK1296656T3 (sh)
EC (1) ECSP024401A (sh)
EG (1) EG24141A (sh)
ES (1) ES2269441T3 (sh)
HK (1) HK1058314A1 (sh)
HR (1) HRP20021009B1 (sh)
HU (1) HU229550B1 (sh)
IL (2) IL153282A0 (sh)
JO (1) JO2247B1 (sh)
MA (1) MA26922A1 (sh)
ME (1) ME00672B (sh)
MX (1) MXPA02012583A (sh)
MY (1) MY129798A (sh)
NO (1) NO332181B1 (sh)
NZ (1) NZ523024A (sh)
PE (1) PE20020101A1 (sh)
PL (1) PL203804B1 (sh)
PT (1) PT1296656E (sh)
RU (1) RU2244542C2 (sh)
SI (1) SI1296656T1 (sh)
TW (1) TWI278325B (sh)
UY (1) UY26799A1 (sh)
WO (1) WO2002000201A2 (sh)
YU (1) YU96602A (sh)
ZA (1) ZA200209649B (sh)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
MXPA02012583A (es) * 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
CN1325050C (zh) * 2002-04-26 2007-07-11 霍夫曼-拉罗奇有限公司 包含脂肪酶抑制剂和葡甘露聚糖的药物组合物
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
EP1699431B1 (en) 2003-12-12 2015-08-19 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US20080269223A1 (en) * 2004-04-06 2008-10-30 Saibal Chakravorty Mouth Dissolvable and Meltable, and Water Dispersable Delivery Formulation
EP1790966A1 (en) * 2004-09-15 2007-05-30 Banyu Pharmaceutical Co., Ltd. SAMPLING METHOD AND SAMPLING DEVICE, AND logD MEASURING METHOD AND logD MEASURING SYSTEM
WO2006073333A2 (fr) * 2004-12-31 2006-07-13 Mikhail Yurievich Gotovsky Preparations de resonance magnetique, et dispositif permettant de selectionner individuellement de telles preparations afin d'augmenter l'activite d'un organisme dans des conditions environnementales actuelles
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
WO2006110809A2 (en) * 2005-04-12 2006-10-19 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
US20070060610A1 (en) * 2005-06-16 2007-03-15 Wempe Michael F Methods and pharmaceutical formulations for increasing bioavailability
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
EP1951186A4 (en) 2005-10-19 2009-11-04 Menni Menashe Zinger METHODS FOR TREATING HYPERHIDROSIS
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
KR20080097468A (ko) 2006-02-20 2008-11-05 추가이 세이야쿠 가부시키가이샤 인산 오셀타미비어 함유 의약 조성물
JP2009530614A (ja) 2006-03-16 2009-08-27 デューク ユニバーシティ フーリエ領域光コヒーレンス・トモグラフィーに基づく実時間直角位相投影を実行するための方法、システム及びコンピュータプログラム製品
CN1820744B (zh) 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
US20080286349A1 (en) * 2007-05-18 2008-11-20 Youhei Nomoto Systems, devices, and methods for passive transdermal delivery of active agents to a biological interface
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
MX2010004072A (es) * 2007-10-15 2010-09-14 Inventis Dds Pvt Ltd Composicion farmaceutica de orlistat.
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) * 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
CA2986751A1 (en) 2009-03-27 2010-09-30 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
CN102459568A (zh) 2009-05-26 2012-05-16 先进生物营养公司 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法
EP2482802A4 (en) * 2009-09-29 2013-08-07 Michael Burnet NEW PESTICIDE FORMULATIONS
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
KR101800773B1 (ko) * 2010-04-07 2017-11-23 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 보존안정성이 우수한 ｓ-아데노실-ｌ-메티오닌 함유 건조 효모 조성물 및 그 제조 방법
LT2603100T (lt) 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Stabilizuojanti kompozicija, skirta biologinių medžiagų sausam saugojimui
EP2632437A4 (en) 2010-10-29 2014-03-19 Univ Western Health Sciences TERNARY MIX FORMULATIONS
MX341035B (es) 2011-03-01 2016-08-03 Procter & Gamble Sustrato solido desintegrable poroso para aplicaciones para el cuidado personal.
IN2014DN08599A (sh) 2012-03-23 2015-05-22 Advanced Bionutrition Corp
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
WO2016210251A1 (en) 2015-06-25 2016-12-29 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
AU2016297986B8 (en) 2015-07-29 2020-06-11 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
JP2020504620A (ja) 2016-12-28 2020-02-13 アスカス バイオサイエンシーズ， インコーポレイテッド 複雑な不均一コミュニティの完全微生物株の解析、その機能的関連性及び相互作用の決定、ならびにそれに基づく生物反応性の改変剤の同定及び合成、のための方法、装置、及びシステム
MX2019007760A (es) 2016-12-28 2020-02-10 Ascus Biosciences Inc Metodos, aparatos y sistemas para analisis de cepa de microorganismo de comunidades heterogeneas complejas con analisis rastreador, determinacion de relaciones funcionales e interacciones de estas, y sintesis de agrupaciones microbianas que incluyen agrupaciones microbianas dosificadas y agrupaciones microbianas inoculativas.
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
CA2546660C (en) 1995-02-27 2009-08-11 Gilead Sciences Inc. Selective inhibitors of viral or bacterial neuraminidase
ATE305453T1 (de) 1995-02-27 2005-10-15 Gilead Sciences Inc Selektive inhibitoren viraler oder bakterieller neuraminidase
WO1996040077A2 (en) * 1995-06-07 1996-12-19 Quadrant Holdings Cambridge Limited Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
JP2000508649A (ja) * 1996-04-16 2000-07-11 ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム 速崩解性経口剤形物
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
EP1097705A2 (en) * 1996-10-14 2001-05-09 F. Hoffmann-La Roche Ag Process for the manufacture of a pulverous preparation
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
CA2326349A1 (en) * 1998-04-09 1999-10-21 F. Hoffmann-La Roche Ag Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
JP3761783B2 (ja) 1998-08-14 2006-03-29 エフ．ホフマン−ラ ロシュ アーゲー リパーゼ阻害剤とキトサンを含む製薬学的組成物
JP3774118B2 (ja) 1998-08-14 2006-05-10 エフ．ホフマン−ラ ロシュ アーゲー リパーゼ阻害剤を含む製薬学的組成物
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
DE60039379D1 (de) 1999-02-10 2008-08-21 Pfizer Prod Inc Pharmazeutische feste Dispersionen
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
MXPA02012583A (es) * 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.

Also Published As

Publication number Publication date
BRPI0112014B1 (pt) 2016-09-13
PL365803A1 (en) 2005-01-10
ZA200209649B (en) 2004-03-10
CZ2003212A3 (cs) 2003-06-18
KR20030023880A (ko) 2003-03-20
NO332181B1 (no) 2012-07-16
HUP0302060A2 (hu) 2003-09-29
IL153282A (en) 2008-03-20
JP2004501184A (ja) 2004-01-15
MEP90608A (en) 2011-12-20
DE60121953T2 (de) 2007-03-08
YU96602A (sh) 2005-03-15
RU2244542C2 (ru) 2005-01-20
AR029278A1 (es) 2003-06-18
NO20026197D0 (no) 2002-12-23
PT1296656E (pt) 2006-12-29
HUP0302060A3 (en) 2006-07-28
WO2002000201A2 (en) 2002-01-03
TWI278325B (en) 2007-04-11
MY129798A (en) 2007-04-30
AU8184601A (en) 2002-01-08
WO2002000201A3 (en) 2002-04-18
CZ301813B6 (cs) 2010-06-30
KR100557845B1 (ko) 2006-03-10
MA26922A1 (fr) 2004-12-20
EP1296656A2 (en) 2003-04-02
JP2007302683A (ja) 2007-11-22
US20020018812A1 (en) 2002-02-14
EP1296656B1 (en) 2006-08-02
CY1105714T1 (el) 2010-12-22
ES2269441T3 (es) 2007-04-01
SI1296656T1 (sl) 2006-12-31
DK1296656T3 (da) 2006-11-27
HK1058314A1 (en) 2004-05-14
PL203804B1 (pl) 2009-11-30
US6534087B2 (en) 2003-03-18
AU2001281846B2 (en) 2006-04-27
US20060134205A1 (en) 2006-06-22
CA2411153A1 (en) 2002-01-03
HU229550B1 (en) 2014-01-28
CN1236764C (zh) 2006-01-18
HRP20021009B1 (en) 2011-07-31
MXPA02012583A (es) 2003-04-10
NZ523024A (en) 2004-08-27
UY26799A1 (es) 2001-12-28
CA2411153C (en) 2007-01-30
NO20026197L (no) 2002-12-23
HRP20021009A2 (en) 2004-02-29
ATE334662T1 (de) 2006-08-15
DE60121953D1 (de) 2006-09-14
CN1438880A (zh) 2003-08-27
BR0112014A (pt) 2003-05-13
EG24141A (en) 2008-08-06
US7074431B2 (en) 2006-07-11
JP4149803B2 (ja) 2008-09-17
JO2247B1 (en) 2004-10-07
US20030039614A1 (en) 2003-02-27
ME00672B (me) 2011-12-20
ECSP024401A (es) 2003-02-06
PE20020101A1 (es) 2002-02-12

Similar Documents

Publication Publication Date Title
IL153282A0 (en) Method for preparing a pharmaceutical composition
EE200300170A (et) Meetod pulbriliste kompositsioonide valmistamiseks
IL150542A0 (en) Method for preparing hydroxypicolinic acid derivatives
EP1277787A4 (en) PROCESS FOR PREPARING A MICROSPHERE
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
AU2001237482A1 (en) Continuous method for preparing pharmaceutical granules
IL158390A0 (en) Method for manufacturing a low dose pharmaceutical composition
AU9564401A (en) Method for preparing a trademark registration request
HK1039117B (zh) 新的哌啶-4-磺酰胺化合物、其製備方法和含有它們的藥物組合物
HUP0300160A3 (en) Process for preparing (+)-cis-sertraline
PL359373A1 (en) New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them
IL144176A0 (en) Method for preparing a benzylic-type ether
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
HU0104405D0 (en) Process for preparing imidachlopid
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
PL360090A1 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
AU4663601A (en) Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin
EP1307180A4 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
IL154825A0 (en) A METHOD FOR PRODUCING Delta1-PYRROLINES
GB0004365D0 (en) Preparation method for oxazoline compounds
HUP0500959A2 (en) Method for preparing latex
HK1040247A1 (zh) 新穎的環丁烷並吲羧酰胺化合物、其製備方法和含有它們的藥物組合物
AU7618601A (en) A method of preparing a pharmaceutical composition
IL131317A0 (en) A binder for pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed